These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 32073142)

  • 81. Tumour characteristics and surgical treatment of renal cell carcinoma in Sweden 2005-2010: a population-based study from the national Swedish kidney cancer register.
    Thorstenson A; Bergman M; Scherman-Plogell AH; Hosseinnia S; Ljungberg B; Adolfsson J; Lundstam S
    Scand J Urol; 2014 Jun; 48(3):231-8. PubMed ID: 24666102
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Comparable survival outcome between acquired cystic disease associated renal cell carcinoma and clear cell carcinoma in patients with end-stage renal disease: a multi-institutional central pathology study.
    Kondo T; Sassa N; Yamada H; Takagi T; Iizuka J; Kobayashi H; Yoshida K; Fukuda H; Ishihara H; Tanabe K; Tsuzuki T
    Pathology; 2021 Oct; 53(6):720-727. PubMed ID: 33947521
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Prognostic value of immunological profile based on CD8+ and FoxP3+ T lymphocytes in the peritumoral and intratumoral subsites for renal cell carcinoma.
    Teke K; Yaprak Bayrak B; Yuksekkaya M; Uslubas AK; Kosem ME; Yilmaz H; Kara O; Dillioglugil O
    Int Urol Nephrol; 2020 Dec; 52(12):2289-2299. PubMed ID: 32761342
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Presence of tumour-infiltrating FOXP3+ lymphocytes correlates with immature tumour angiogenesis in renal cell carcinomas.
    Zhan HL; Gao X; Zhou XF; Pu XY; Wang DJ
    Asian Pac J Cancer Prev; 2012; 13(3):867-72. PubMed ID: 22631663
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Deep Sequencing of T-cell Receptor DNA as a Biomarker of Clonally Expanded TILs in Breast Cancer after Immunotherapy.
    Page DB; Yuan J; Redmond D; Wen YH; Durack JC; Emerson R; Solomon S; Dong Z; Wong P; Comstock C; Diab A; Sung J; Maybody M; Morris E; Brogi E; Morrow M; Sacchini V; Elemento O; Robins H; Patil S; Allison JP; Wolchok JD; Hudis C; Norton L; McArthur HL
    Cancer Immunol Res; 2016 Oct; 4(10):835-844. PubMed ID: 27587469
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Perivascular Neuropilin-1 expression is an independent marker of improved survival in renal cell carcinoma.
    Morin E; Lindskog C; Johansson M; Egevad L; Sandström P; Harmenberg U; Claesson-Welsh L; Sjöberg E
    J Pathol; 2020 Apr; 250(4):387-396. PubMed ID: 31880322
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Comprehensive assessment of T-cell repertoire following autologous hematopoietic stem cell transplantation for treatment of type 1 diabetes using high-throughput sequencing.
    Zhang J; Hu M; Wang B; Gao J; Wang L; Li L; Chen S; Cui B; Gu W; Wang W; Ning G
    Pediatr Diabetes; 2018 Nov; 19(7):1229-1237. PubMed ID: 30022578
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Prognostic implications of the immunohistochemical expression of human kallikreins 5, 6, 10 and 11 in renal cell carcinoma.
    Petraki CD; Gregorakis AK; Vaslamatzis MM; Papanastasiou PA; Yousef GM; Levesque MA; Diamandis EP
    Tumour Biol; 2006; 27(1):1-7. PubMed ID: 16340244
    [TBL] [Abstract][Full Text] [Related]  

  • 89. The relationships among tumor-infiltrating lymphocytes, histopathologic findings, and long-term clinical follow-up in renal cell carcinoma.
    Kolbeck PC; Kaveggia FF; Johansson SL; Grune MT; Taylor RJ
    Mod Pathol; 1992 Jul; 5(4):420-5. PubMed ID: 1495948
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Circulating T-Cell Repertoires Correlate With the Tumor Response in Patients With Breast Cancer Receiving Neoadjuvant Chemotherapy.
    Cai G; Guan Z; Jin Y; Su Z; Chen X; Liu Q; Wang C; Yin X; Zhang L; Ye G; Luo W
    JCO Precis Oncol; 2022 Jan; 6():e2100120. PubMed ID: 35025620
    [TBL] [Abstract][Full Text] [Related]  

  • 91. TcR-α recombinations in renal cell carcinoma exome files correlate with an intermediate level of T-cell exhaustion biomarkers.
    Mai AT; Tong WL; Tu YN; Blanck G
    Int Immunol; 2018 Feb; 30(1):35-40. PubMed ID: 29361059
    [TBL] [Abstract][Full Text] [Related]  

  • 92. The repertoire features of T cell receptor β-chain of different age and gender groups in healthy Chinese individuals.
    Lian J; Liu J; Yue Y; Li F; Chen X; Zhang Z; Ping Y; Qin G; Li L; Zhang K; Liu S; Zhang L; Qiao S; Liu N; Zheng Y; Wu J; Zeng Q; Zhang Y
    Immunol Lett; 2019 Apr; 208():44-51. PubMed ID: 30905825
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Next-Generation Sequencing Analysis of the Human TCRγδ+ T-Cell Repertoire Reveals Shifts in Vγ- and Vδ-Usage in Memory Populations upon Aging.
    Kallemeijn MJ; Kavelaars FG; van der Klift MY; Wolvers-Tettero ILM; Valk PJM; van Dongen JJM; Langerak AW
    Front Immunol; 2018; 9():448. PubMed ID: 29559980
    [TBL] [Abstract][Full Text] [Related]  

  • 94. A novel approach to T-cell receptor beta chain (TCRB) repertoire encoding using lossless string compression.
    Konstantinovsky T; Yaari G
    Bioinformatics; 2023 Jul; 39(7):. PubMed ID: 37417959
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Profiling of T cell repertoire in peripheral blood of patients from type 2 diabetes with complication.
    Yin Y; Sheng Y; Gao S; Zhang J; Wang W; Liu Y; Xu T; Zhang Y
    BMC Immunol; 2024 Jan; 25(1):10. PubMed ID: 38297222
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Immunological classification of renal cell carcinoma patients based on phenotypic analysis of immune check-point molecules.
    Kawashima A; Kanazawa T; Goto K; Matsumoto M; Morimoto-Okazawa A; Iwahori K; Ujike T; Nagahara A; Fujita K; Uemura M; Nonomura N; Wada H
    Cancer Immunol Immunother; 2018 Jan; 67(1):113-125. PubMed ID: 28975380
    [TBL] [Abstract][Full Text] [Related]  

  • 97. The dysfunctional immune response in renal cell carcinoma correlates with changes in the metabolic landscape of ccRCC during disease progression.
    Annels NE; Denyer M; Nicol D; Hazell S; Silvanto A; Crockett M; Hussain M; Moller-Levet C; Pandha H
    Cancer Immunol Immunother; 2023 Dec; 72(12):4221-4234. PubMed ID: 37940720
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Evaluation of ARK5 and SIRT3 expression in renal cell carcinoma and their clinical significance.
    Elkady N; Aldesoky AI; Dawoud MM
    Diagn Pathol; 2023 Nov; 18(1):125. PubMed ID: 37996927
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Sex differences in renal cell carcinoma: a single-cell analysis reveals exhausted CD8
    Ning K; Peng Y; Jiang Y; Li Z; Luo X; Lin L; Deng M; Wu Y; Huang T; Huang Y; Xie Y; Yang X; Zhang M; Xiong L; Zou X; Zhou Z; Zhou F; Dong P; Yu C; Zhang Z
    Biol Sex Differ; 2023 Sep; 14(1):58. PubMed ID: 37715192
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Applying single-cell technologies to clinical pathology: progress in nephropathology.
    Stewart BJ; Clatworthy MR
    J Pathol; 2020 Apr; 250(5):693-704. PubMed ID: 32125696
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.